abdominal tb

腹部结核病
  • 文章类型: Journal Article
    尝试通过利用基于金纳米颗粒(AuNP)的I-PCR来提高PCR扩增免疫测定(I-PCR)诊断腹部结核病例的功效。其中AuNP用检测抗体/寡核苷酸进行功能化,表现出84.3%的灵敏度和95.1%的特异性。该测定将改进用于腹部TB诊断的正在进行的算法。
    Attempts were made to improve the efficacy of PCR amplified immunoassay (I-PCR) for diagnosing abdominal TB cases by utilizing the gold nanoparticle (AuNP)-based I-PCR, where AuNPs were functionalized with detection antibodies/oligonucleotides that exhibited 84.3% sensitivity and 95.1% specificity. This assay would improve the ongoing algorithms used in abdominal TB diagnosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:腹部结核的诊断是一项紧迫的任务,因为不同的解剖部位和非特异性临床表现与其他疾病非常相似。大多数可用的诊断方式产生低灵敏度并且需要专业知识来处理专用设备。因此,迫切需要开发一种快速可靠的诊断测试,从而减少不必要的发病率。因此,我们设计了一种多靶向环介导等温扩增(MT-LAMP)诊断腹部结核的方法.
    方法:我们评估了MT-LAMP(使用mpt64和IS6110)在腹水和肠/腹膜活检中诊断腹部结核,并将这些结果与使用相同靶标的多重PCR(M-PCR)进行比较。采用凝胶电泳和视觉检测方法对MT-LAMP产品进行分析,也就是说,羟基萘酚蓝与SYBR绿Ⅰ反应。
    结果:在疑似(n=42)和全腹结核(n=52)病例中,敏感性分别为80.9%和84.6%。分别通过基于凝胶的MT-LAMP,在非TB对照中具有97.3%(n=37)的特异性。值得注意的是,基于凝胶/SYBRGreenIMT-LAMP在临床可疑和全腹TB病例中的敏感性均显着高于M-PCR(P<0.05)。此外,用SYBRGreenI获得的灵敏度与基于凝胶的MT-LAMP相当,而SYBRGreenI的特异性稍低(94.6%),与基于凝胶的MT-LAMP相比。
    结论:基于凝胶的和SYBRGreenMT-LAMP对诊断腹部TB表现出同等的敏感性。因为SYBRGreenLAMP比基于凝胶的检测更容易执行,我们目前专注于提高该测定的特异性,以开发诊断试剂盒。
    OBJECTIVE: Diagnosis of abdominal TB is an exigent task due to variable anatomical sites and non-specific clinical manifestations that closely resemble other diseases. Most of the available diagnostic modalities yield low sensitivities and need expertise to handle the specialized equipment. Hence, there is an urgent need to develop a rapid and reliable diagnostic test, so as to reduce the unnecessary morbidity. Therefore, we designed a multi-targeted loop-mediated isothermal amplification (MT-LAMP) for diagnosing abdominal TB.
    METHODS: We evaluated an MT-LAMP (using mpt64 and IS6110) to diagnose abdominal TB within ascitic fluids and intestinal/peritoneal biopsies and compared these results with multiplex-PCR (M-PCR) using the same targets. MT-LAMP products were analyzed by gel electrophoresis and visual detection methods, that is, hydroxy naphthol blue and SYBR Green I reaction.
    RESULTS: Sensitivities of 80.9% and 84.6% were obtained in suspected (n = 42) and total abdominal TB (n = 52) cases, respectively by gel-based MT-LAMP, with 97.3% (n = 37) specificity in non-TB controls. Notably, sensitivities attained by gel-based/SYBR Green I MT-LAMP in both clinically suspected and total abdominal TB cases were significantly higher (P < 0.05) than M-PCR. Furthermore, sensitivity obtained with SYBR Green I was equivalent to that of gel-based MT-LAMP, while somewhat lesser specificity (94.6%) was attained with SYBR Green I, compared with gel-based MT-LAMP.
    CONCLUSIONS: Both gel-based and SYBR Green MT-LAMP exhibited equivalent sensitivities to diagnose abdominal TB. Because SYBR Green LAMP is easier to perform than a gel-based assay, we are currently focused on improving the specificity of this assay so as to develop a diagnostic kit.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    准确及时地检测结核病(TB)对于减少传播至关重要。本研究旨在评估XpertMTB/RIFUltra对粪便样本的准确性,并通过荟萃分析系统地回顾XpertMTB/RIFUltra对不同样本类型的表现。涂片阴性肺结核(PTB)的粪便样本,颈淋巴结结核,和腹部结核病患者在XpertMTB/RIFUltra系统上进行测试。对一组44项研究进行了荟萃分析。数据按样本类型分组,并计算XpertMTB/RIFUltra的合并敏感性和特异性。XpertMTB/RIFUltra对粪便样本的敏感性为100%,对涂片阴性的PTB,颈部淋巴结结核占27.27%,50%为腹部结核病患者,对所有纳入的结核病组具有100%的特异性。所有PTB样本的汇总估计显示84.2%的灵敏度和94.5%的特异性,和EPTB样本显示88.6%的敏感性和96.4%的特异性。在我们的荟萃分析中包括的所有样本类型中,尿液显示EPTB诊断的最佳表现。这项初步研究支持使用粪便作为XpertMTB/RIFUltra的替代非侵入性样品进行快速测试,适用于PTB和EPTB诊断。
    Precise and timely detection of tuberculosis (TB) is crucial to reduce transmission. This study aims to assess the accuracy of Xpert MTB/RIF Ultra on stool samples and systematically review the performance of Xpert MTB/RIF Ultra with different sample types by meta-analysis. Stool samples of smear-negative pulmonary TB (PTB), cervical lymph node TB, and abdominal TB patients were tested on the Xpert MTB/RIF Ultra system. Meta-analysis was performed on a set of 44 studies. Data were grouped by sample type, and the pooled sensitivity and specificity of Xpert MTB/RIF Ultra were calculated. The sensitivity of Xpert MTB/RIF Ultra with stool samples was 100% for smear-negative PTB, 27.27% for cervical lymph node TB, and 50% for abdominal TB patients, with 100% specificity for all included TB groups. The summary estimate for all PTB samples showed 84.2% sensitivity and 94.5% specificity, and EPTB samples showed 88.6% sensitivity and 96.4% specificity. Among all sample types included in our meta-analysis, urine showed the best performance for EPTB diagnosis. This pilot study supports the use of stool as an alternative non-invasive sample on Xpert MTB/RIF Ultra for rapid testing, suitable for both PTB and EPTB diagnosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:腹部结核(TB)是肺外结核(EPTB)的常见缩影,其中腹膜和肠TB是最普遍的形式。腹部结核的诊断是一个艰巨的挑战,由于不同的解剖位置,标本的小杆菌性质和模拟其他腹部疾病的非典型临床表现,如克罗恩病和恶性肿瘤。在这次审查中,我们对腹部结核的诊断进行了全面的研究。
    方法:用于腹部结核病诊断的各种方式包括临床特征,成像,细菌学测试(涂片/培养),组织病理学/细胞学观察,干扰素-γ释放试验和核酸扩增试验(NAAT)。在NAAT中,环介导等温扩增试验,PCR,多重PCR,巢式PCR,实时PCR和GeneXpert®MTB/RIF进行了讨论。通过实时PCR在腹水中鉴定循环结核分枝杆菌无细胞DNA是另一种有用的方法。
    结论:几种新的分子/免疫学方法,比如GeneXpertUltra,适体连接的固定化吸附剂测定,免疫PCR(I-PCR)和基于纳米颗粒的I-PCR最近已被开发用于检测肺结核和几种EPTB类型,这也可以探索腹部结核病的诊断。腹部结核的准确和及时的诊断可以开始早期治疗,以减少并发症。即腹痛,腹水,腹胀,肠梗阻/穿孔,等。,避免手术参与。腹部结核(TB)是肺外结核(EPTB)的一种表现,其中腹膜和肠道结核是两种主要形式。由于临床样本中存在低细菌载量和非特异性临床表现,腹部结核病的诊断很困难,因为它模拟了其他疾病,例如炎症性肠病。腹部恶性肿瘤,等。细菌学测试(涂片/培养)几乎由于敏感性差而失败,并且并不总是可能获得代表性的组织样品进行组织病理学和细胞学观察。近年来,分子测试,即核酸扩增测试(NAAT),如PCR/多重PCR(M-PCR),巢式PCR和GeneXpert被广泛使用。很明显,PCR/M-PCR和巢式PCR表现出合理的良好敏感性/特异性,虽然GeneXpert在大多数研究中显示灵敏度低,但特异性高,从而有助于肠结核和克罗恩病的鉴别诊断。Further,描述了用于肺结核和其他EPTB类型的新型分子/免疫学测试,这些测试也可用于诊断腹部TB。腹部结核的可靠和快速诊断将启动抗结核治疗的早期开始,并减少严重的并发症。
    BACKGROUND: Abdominal tuberculosis (TB) is a common epitome of extrapulmonary TB (EPTB), wherein peritoneal and intestinal TB are the most prevalent forms. Diagnosis of abdominal TB is a daunting challenge owing to variable anatomical locations, paucibacillary nature of specimens and atypical clinical presentations that mimic other abdominal diseases, such as Crohn\'s disease and malignancies. In this review, we made a comprehensive study on the diagnosis of abdominal TB.
    METHODS: Various modalities employed for abdominal TB diagnosis include clinical features, imaging, bacteriological tests (smear/culture), histopathological/cytological observations, interferon-gamma release assays and nucleic acid amplification tests (NAATs). Among NAATs, loop-mediated isothermal amplification assay, PCR, multiplex-PCR, nested PCR, real-time PCR and GeneXpert® MTB/RIF were discussed. Identification of circulating Mycobacterium tuberculosis cell-free DNA by real-time PCR within ascitic fluids is another useful approach.
    CONCLUSIONS: Several novel molecular/immunological methods, such as GeneXpert Ultra, aptamer-linked immobilized sorbent assay, immuno-PCR (I-PCR) and nanoparticle-based I-PCR have recently been developed for detecting pulmonary TB and several EPTB types, which may also be explored for abdominal TB diagnosis. Precise and prompt diagnosis of abdominal TB may initiate an early therapy so as to reduce the complications, i.e. abdominal pain, ascites, abdominal distension, intestinal obstruction/perforation, etc., and avoid surgical involvement.Plain Language SummaryAbdominal tuberculosis (TB) is a manifestation of extrapulmonary TB (EPTB), where peritoneal and intestinal TB are two major forms. Diagnosis of abdominal TB is difficult owing to low bacterial load present in clinical samples and non-specific clinical presentations as it mimics other diseases such as inflammatory bowel diseases, abdominal malignancies, etc. Bacteriological tests (smear/culture) almost fail owing to poor sensitivities and it is not always possible to get representative tissue samples for histopathological and cytological observations. In recent years, molecular tests i.e. nucleic acid amplification tests (NAATs), such as PCR/multiplex-PCR (M-PCR), nested PCR and GeneXpert are widely employed. Markedly, PCR/M-PCR and nested PCR exhibited reasonable good sensitivities/specificities, while GeneXpert revealed low sensitivity in most of the studies but high specificity, thus it could assist in differential diagnosis of intestinal TB and Crohn\'s disease. Further, novel molecular/immunological tests employed for pulmonary TB and other EPTB types were described and those tests can also be utilized to diagnose abdominal TB. Reliable and rapid diagnosis of abdominal TB would initiate an early start of anti-tubercular therapy and reduce the severe complications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    艾滋病毒感染者(PLHIV)中结核病的比例很高。由于这种活跃的结核病病例发现被建议用于高结核病负担国家的艾滋病毒诊所。目前,痰液检查和胸部X线检查是建议用于HIV感染的结核病推定的一线检查。即使通过现有的程序性强化病例发现方案,PLHIV中经常发生的腹部结核病也可能被错过。这项研究评估了超声检查(USG)在HIV诊所中积极发现腹部结核病的常规应用。
    对印度一家结核病医院的HIV诊所8年数据进行回顾性分析。患者接受了胸部X光检查,痰液检查,进入艾滋病毒护理时的USG腹部和常规血液检查。病例表格被仔细检查以诊断结核病,USG发现和CD4细胞计数。腹部TB被分类为可能或可能的TB。可能的结核病是基于存在两个主要的USG(腹部)发现,提示活动性结核病。或一个主要的USG发现,至少有两个次要的USG发现或至少两个症状,或任何USG发现在另一个地点有微生物学证实的活动性结核病。可能的结核病是基于USG的一项主要发现,或存在两个轻微的USG发现,至少有两个症状。未获得细菌学证实。
    八百八十九人PLHIV接受了基线USG腹部。在HIV临床登记时,已经诊断出结核病的340例中有113例,在新诊断出结核病的91例中有87例患有腹部结核病。非腹部症状,比如体重减轻,53%的病例出现发烧和咳嗽,22%的病例根本没有症状。腹部淋巴结肿大伴中央区,腹膜炎,脾微凹陷,肠管增厚和肝脾肿大是这些病例的USG表现.
    腹部结核是PLHIV中常见的结核部位,表现为非腹部症状。它可以很容易地检测到的特征在一个简单的腹部超声。腹部USG应该是强化结核病病例发现算法的重要组成部分,用于生活在高结核病负担环境中的HIV感染者。
    High proportion of TB in people living with HIV (PLHIV) is undiagnosed. Due to this active TB case finding is recommended for HIV clinics in high TB burden countries. Presently sputum examination and chest radiography are frontline tests recommended for HIV infected TB presumptives. Abdominal TB which occurs frequently in PLHIV may be missed even by existing programmatic intensified case finding protocols. This study evaluated the routine use of ultrasonography (USG) for active case finding of abdominal TB in HIV clinics.
    Retrospective analysis of eight years\' data from an HIV Clinic in a TB hospital in India. Patients underwent chest x-ray, sputum examination, USG abdomen and routine blood tests at entry to HIV care. Case forms were scrutinized for diagnosis of TB, USG findings and CD4 cell counts. Abdominal TB was classified as probable or possible TB. Probable TB was based on presence of two major USG (abdomen) findings suggestive of active TB, or one major USG finding with at least two minor USG findings or at least two symptoms, or any USG finding with microbiologically confirmed active TB at another site. Possible TB was based on the presence of one major USG finding, or the presence of two minor USG findings with at least two symptoms. Bacteriological confirmation was not obtained.
    Eight hundred and eighty-nine people PLHIV underwent a baseline USG abdomen. One hundred and thirteen of 340 cases already diagnosed with TB and 87 of the 91 newly diagnosed with TB at time of HIV clinic registration had abdominal TB. Non-abdominal symptoms like weight loss, fever and cough were seen in 53% and 22% cases had no symptoms at all. Enlarged abdominal lymph nodes with central caseation, ascitis, splenic microabsesses, bowel thickening and hepatosplenomegaly were the USG findings in these cases.
    Abdominal TB is a frequent TB site in PLHIV presenting with non-abdominal symptoms. It can be easily detected on basis of features seen on a simple abdominal ultrasound. Abdominal USG should be essential part of intensified TB case finding algorithms for HIV infected people living in high TB burden settings.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    The incidence of extrathoracic tuberculosis (ETB) continues to increase slowly, especially in immunocompromised and multidrug-resistant tuberculosis (TB) patients. ETB manifests with nonspecific clinical symptoms, and being less frequent, is less familiar to most physicians. Imaging modalities of choice are computed tomography (lymphadenopathy and abdominal TB) and MR imaging (central nervous system and musculoskeletal system TB). ETB commonly involves multiple organ systems with characteristic imaging findings that permit accurate diagnosis and timely management.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Primary peritoneal serous carcinoma (PPSC) is a rare malignancy that arises primarily from peritoneal surface epithelium. However there are limited studies on these tumors even in world literature. To study the clinical, pathologic profile, outcome and prognostic features of PPSC. A 5 year retrospective study of PPSC diagnosed and treated at our centre was conducted. The pathological specimen of PPSC diagnosed from January 2008 to December 2012 were reviewed by gynaeconcopathologists. The diagnosis was based on GOG criteria, complemented with IHC. Majority of the patients underwent upfront de-bulking surgery. Postoperatively, six cycles of combination chemotherapy with paclitaxel (175 mg/m(2)) and carboplatin (AUC 6) was administered every 3 weekly. These patients were analysed for progression free survival (PFS), this was correlated with stage and surgical adequacy. The median age of presentation was 56 years. The total number of ovarian cancers treated during study period was 374. The 30 cases were clinically suspected to have primary peritoneal carcinoma (PPC) on pre- and intra-operatve gross findings, but further evaluation with histopathological examination, IHC and GOG criteria revealed only 10 cases were genuine PPSC. The remaing 20 cases; 13 were found to poorly differentiated ovarian carcinomas, six were primary fallopian tube carcinoma and one was appendicular carcinoma. The 10 (2.7 %) cases of the 374 were eligible for the PPSC analysis. The two (20 %) of the 10 cases had family history of breast and ovarian cancers, two (20 %) cases were diagnosed as abdominal tuberculosis (TB) prior referral to our centre. Radiological presentation includes gross ascites, with omental caking and normal adenexa. The eight (80 %) of 10 cases presented with stage IIIC and other two cases (20 %) with stage IV disease. The eight (80 %) of 10 cases underwent upfront surgery; six (75 %) of these eight cases had optimal cytoreduction, i.e. residual disease (RD) <1 cm or no visible disease (R0) and other two (25 %) suboptimal cytoreduction. The two (20 %) of 10 cases with stage IV disease received neoadjuvant chemotherapy (NACT) followed by interval cytoreduction. After debulking surgery the most useful IHC marker include CK7+, CK20-, CA125+, WT-1+, and GCDFP- . At median follow up of 24 months (range 3-60 months), the median progression free survival (PFS) was 22 months, while the estimated 5 year PFS was 18 %. Stage IV disease and suboptimal surgery had poor outcome. The PPSC presents with advanced stage disease and are observed to be misdiagnosed abdominal TB in tropical countries. The GOG criteria and IHC complement the diagnosis. These have poor outcome despite optimal care, highlighting need for larger studies on this disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    BACKGROUND: The case series presented here demonstrates that the pathology encountered during inguinal hernia repair can often provide clues to concurrent pathology; the well trained surgeon\'s broader medical knowledge can lead to earlier diagnosis.
    METHODS: The case series examines four cases of men presenting with inguinal hernias, who were found to have concurrent abdominal pathology after further investigation of the intraoperative findings of the surgeon.
    CONCLUSIONS: Operating surgeons not only require the necessary surgical skills to deal with the unexpected, but must also rely on their ability to think laterally when interpreting atypical incidental findings during \'routine\' procedures.
    CONCLUSIONS: Experience and knowledge gained through a surgeon\'s career is essential to enable them to correctly interpret their intraoperative findings and potentially diagnose concurrent pathology. The authors believe that surgical care practitioners, trained in just 2 years, would lack these essential skills.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号